On the morning of the 2nd, ABL Bio is drawing investors' attention by showing an upward trend despite the overall weakness in the KOSDAQ market.

As of the morning of the same day, ABL Bio is trading at 102,300 won, up 800 won (0.79%) from the previous trading day. During the session, it rose to as high as 103,300 won, and trading volume is also steadily increasing.

While the domestic stock market is experiencing a downturn in the KOSPI due to a correction in U.S. semiconductor stocks and foreign selling pressure, ABL Bio is maintaining a relatively solid trend as expectations for its individual growth momentum come to the forefront.

Recently, the company raised market expectations by revealing its global business strategy at the 'BIO International Convention (BIO USA)' held in the United States.

However, some point out that due to the nature of biotech companies, stock price volatility may expand depending on clinical trial results, technology transfers, and regulatory approvals, requiring a cautious approach.

[This article was written with the assistance of AI. This article is not a recommendation to invest, and the final decision and responsibility for investing lie with the investor.]